Market Overview

Radiotherapy marker is a special type of marker which is used during the image-guided radiation therapy. Radiotherapy marker as also referred as fiducial markers. The main function of radiotherapy markers is to locate the tumor location which allows the medical professionals to perform the radiotherapy with greater accuracy.

The accuracy of radiotherapy markers also helps to deliver the maximum radiation dose to the tumor without hampering the healthy tissues. Before having radiation therapy with radiotherapy markers, medical professionals instruct the patient regarding the preparation of treatment. A patient needs to stop few medications such as aspirin, NSAIDs, or blood thinners some days before the procedure.

Radiotherapy markers are implanted inside the patient body using a delivery device which looks quite similar as a biopsy needle. Radiotherapy markers are placed inside the patient body into the area of the lesion with the help of computed tomography or ultrasound.

The primary factor driving the growth of Radiotherapy Markers market is increasing the prevalence of prostate cancer. Moreover, radiotherapy markers provide a greater accuracy to the medical professional to use radiation therapy for treatment of tumor will boost the demand of radiotherapy markers market. Also, the rising adoption of radiotherapy markers for the treatment of cancer will propel the growth of radiotherapy markers market over the forecast period.

Additionally, rising application of radiotherapy markers for the therapeutic and diagnostic purpose will propel the growth of radiotherapy markers market. The high cost of gold radiotherapy markers is the major factor hampering the growth of radiotherapy markers market. Also, the scarcity of medical professional in Latin America and MEA will deter the growth of Radiotherapy Markers market over the forecast period.

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Get FREE Report Sample

Market Segmentation

Based on product type	Polymer-Based Markers Liquid-Based Markers Pure Gold Markers Metal-Based Markers
Based on modality	Magnetic Resonance Imaging CT/CBCT Tomotherapy Proton Therapy Linac Cyberknife
Based on indication	Prostate Cancer Breast Cancer Lung Cancer Stomach Cancer Others
Based on end user	Hospitals Ambulatory Surgical Centers Radiotherapy Centers Cancer Research Institutes

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

Get a Customized Version

Regional Outlook

North America is expected to dominate the global Radiotherapy Markers market due increasing the prevalence of prostate cancer. After North America Radiotherapy Markers market is then followed by Europe due to high healthcare infrastructure in this region. Asia-Pacific is expected to show the faster growth for global radiotherapy markers market owing to rising patient pool suffering from breast cancer in this region.

Latin America and Middle East and Africa is expected to show delayed growth for Radiotherapy Markers market due to lack of healthcare infrastructure and the limited number of medical professionals. India, Russia and Brazil are among few emerging countries in Radiotherapy Markers market.

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Key Players

Some of the key players found across the value chain of Radiotherapy Markers are Eckert & Ziegler BEBIG, Boston Scientific Corporation, Innovative Oncology Solutions, IBA, IZI Medical Products, alphaXRT, Carbon Medical Technologies, CIVCO, Nanovi A/S, Stellar Medicaland, Best Medical International Inc., others.